Clinical Trials/JPRN-UMIN000018530

JPRN-UMIN000018530

Completed

未知

ong term follow-up for infants who was enrolled at 2 months of age into 'Evaluation of depth and thickness in skin, subcutaneous and muscle tissue at vaccination sites in Japanese infants' - Long term follow-up for infants who was enrolled at 2 months of age into 'Evaluation of depth and thickness in skin, subcutaneous and muscle tissue at vaccination sites in Japanese infants'

Japan Vaccine Co.,Ltd0 sites30 target enrollmentAugust 3, 2015

ConditionsA

Overview

Phase: 未知
Intervention: Not specified
Conditions: A
Sponsor: Japan Vaccine Co.,Ltd
Enrollment: 30
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

August 3, 2015

End Date

October 17, 2016

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Japan Vaccine Co.,Ltd

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\) infant who has an abnormality in the measurement target site. (2\) infant with who investigator judges stable and circumference measurements and image inspection is difficult. (3\) infant who is suffering from severe acute and chronic disease. (4\) infant who has an experience of any damage in the arms or legs. (5\) infant who has or experienced all of neurological or muscle disease. (6\) Other, infant who investigator judges ineligible as a subject. (7\) infant whose written consent form is not obtained by his/her representative's own free will.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Child outcomes after prenatal progesterone for prevention of preterm birth, follow-up of the AMPHIA trialPrevention of preterm birth in multiple pregnancy

NL-OMON27515Amsterdam UMC - location AMC300

Not yet recruiting

ong-term follow-up of children born in the PETN studiesP05Slow fetal growth and fetal malnutrition

DRKS00033628niversitätsklinikum Jena228

ong-term follow-up of children exposed in utero to low-dose aspirin for prevention of preterm birth, a follow-up of the APRIL trialPrevention of preterm birth in multiple pregnancy

NL-OMON21183Amsterdam UMC200

Study of clinical course and prognosis of severe asthma in Korea by long-term follow-up

KCT0007960Hanyang University500

ong-term follow-up of the WAS gene therapy studyTreatment of Wiskott-Aldrich SyndromeMedDRA version: 20.0Level: PTClassification code: 10047992Term: Wiskott-Aldrich syndrome Class: 100000004850Therapeutic area: Diseases [C] - Hemic and Lymphatic Diseases [C15]

CTIS2024-512680-31-00Genethon10